E-cadherin mutations in human colorectal cancer cell lines

E-cadherin mutations in human colorectal cancer cell lines

Pokaż inne wersje (1)

Opis bibliograficzny
Główni autorzy:	Wheeler, J, Efstathiou, J, Kim, H, Beck, N, Ilyas, M, Mortensen, N, Bodmer, W
Format:	Journal article
Wydane:	1999

Podobne zapisy

E-cadherin mutations in human colorectal cancer cell lines
od: Wheeler, J, i wsp.
Wydane: (1999)

Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer
od: Wheeler, J, i wsp.
Wydane: (2001)

Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer.
od: Wheeler, J, i wsp.
Wydane: (2001)

The E-cadherin gene (CDH1) variants T340A and L599V in gastric and colorectal cancer patients in Korea.
od: Kim, H, i wsp.
Wydane: (2000)

Allele loss, replication errors and loss of expression of E-cadherin in colorectal cancers.
od: Ilyas, M, i wsp.
Wydane: (1997)

Mutated epithelial cadherin is associated with increased tumorigenicity and loss of adhesion and of responsiveness to the motogenic trefoil factor 2 in colon carcinoma cells.
od: Efstathiou, J, i wsp.
Wydane: (1999)

Mechanisms of inactivation of mismatch repair genes in human colorectal cancer cell lines: the predominant role of hMLH1.
od: Wheeler, J, i wsp.
Wydane: (1999)

Beta-catenin mutations in cell lines established from human colorectal cancers.
od: Ilyas, M, i wsp.
Wydane: (1997)

Characterization of the E-cadherin/catenin complex in colorectal carcinoma cell lines.
od: El-Bahrawy, M, i wsp.
Wydane: (2004)

The low frequency of beta-catenin mutations in cell lines established from human colorectal cancers
od: Ilyas, M, i wsp.
Wydane: (1997)

DNA mismatch repair genes and colorectal cancer.
od: Wheeler, J, i wsp.
Wydane: (2000)

Transforming growth factor beta stimulation of colorectal cancer cell lines: type II receptor bypass and changes in adhesion molecule expression.
od: Ilyas, M, i wsp.
Wydane: (1999)

Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines.
od: Liu, Y, i wsp.
Wydane: (2006)

"Null" HLA A*0101 mutation identified in a colorectal cancer cell line
od: Bicknell, D, i wsp.
Wydane: (2001)

Tumour recurrence is associated with Jass grouping but not with differences in E-cadherin expression in moderately differentiated Dukes' B colorectal cancers.
od: Ilyas, M, i wsp.
Wydane: (1997)

C-terminal Tensin-like (CTEN) is an oncogene which alters cell motility possibly through repression of E-cadherin in colorectal cancer.
od: Albasri, A, i wsp.
Wydane: (2009)

Direct and immune mediated antibody targeting of ERBB receptors in a colorectal cancer cell-line panel.
od: Ashraf, S, i wsp.
Wydane: (2012)

Frequency of germline hereditary non-polyposis colorectal cancer gene mutations in patients with multiple or early onset colorectal adenomas.
od: Beck, N, i wsp.
Wydane: (1997)

Colorectal cancer stem cells.
od: Yeung, T, i wsp.
Wydane: (2009)

Cancer stem cells from colorectal cancer-derived cell lines.
od: Yeung, T, i wsp.
Wydane: (2010)

Mutations within Wnt pathway genes in sporadic colorectal cancers and cell lines.
od: Suraweera, N, i wsp.
Wydane: (2006)

Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells.
od: Efstathiou, J, i wsp.
Wydane: (1998)

Reduced expression of molecules of the cadherin/catenin complex in the transition from colorectal adenoma to carcinoma.
od: Hao, X, i wsp.
Wydane: (1997)

APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits".
od: Rowan, A, i wsp.
Wydane: (2000)

The role of hypermethylation of the hMLH1 promoter region in HNPCC versus MSI+ sporadic colorectal cancers.
od: Wheeler, J, i wsp.
Wydane: (2000)

The role of hypermethylation of the hMLH1 promoter region in HNPCC versus MSI plus sporadic colorectal cancers
od: Wheeler, J, i wsp.
Wydane: (2000)

The role of hypermethylation of the hMLH1 promoter region in HNPCC versus sporadic RER plus colorectal cancers
od: Wheeler, J, i wsp.
Wydane: (2000)

Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer
od: Porter, T, i wsp.
Wydane: (2002)

Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer.
od: Porter, T, i wsp.
Wydane: (2002)

A mutated HLA-A*0101 allele in the colorectal cell line HCA-7.
od: Bicknell, D, i wsp.
Wydane: (2005)

hMLH1 and hMSH2 mutations in families with familial clustering of gastric cancer and hereditary non-polyposis colorectal cancer.
od: Kim, J, i wsp.
Wydane: (2001)

Genetic pathways in colorectal and other cancers.
od: Ilyas, M, i wsp.
Wydane: (1999)

Genetic pathways in colorectal and other cancers.
od: Ilyas, M, i wsp.
Wydane: (1999)

The interactions of APC, E-cadherin and beta-catenin in tumour development and progression.
od: Ilyas, M, i wsp.
Wydane: (1997)

Stem cell differentiation and lumen formation in colorectal cancer cell lines and primary tumors.
od: Ashley, N, i wsp.
Wydane: (2013)

Defining the clinical phenotype of hereditary nonpolyposis colorectal cancer
od: Beck, N, i wsp.
Wydane: (1999)

Nuclear expression of E-cadherin.
od: Chetty, R, i wsp.
Wydane: (2008)

Myofibroblast activation in colorectal cancer lymph node metastases.
od: Yeung, T, i wsp.
Wydane: (2013)

Hypoxia and lineage specification of cell line-derived colorectal cancer stem cells.
od: Yeung, T, i wsp.
Wydane: (2011)

Colorectal cancer prognosis: is it all mutation, mutation, mutation?
od: Hassan, A, i wsp.
Wydane: (2005)